Nanotechnology offers innovative tools and techniques for enhancing the study and application of MHC Class I molecules. Nanoparticles can be engineered to improve the delivery of antigens to MHC Class I pathways, thereby boosting immune responses. Additionally, nanomaterials can be tailored to interact with MHC Class I molecules for diagnostic and therapeutic purposes.